Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Wall St to open higher on oil retreat, tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
Rallybio Corp. (RLYB) PT Lowered to $20 at Jones Trading
March 13, 2024 4:11 PM EDTJones Trading analyst Catherine Novack lowered the price target on Rallybio Corp. (NASDAQ: RLYB) to $20.00 (from $30.00) while maintaining a Buy rating.
The analyst comments "Rallybio reported 4Q23 earnings ( press release ). Earlier this year, the company announced portfolio prioritization to extend runway... More
